Benzinga Global Small Cap Investor Conference :May 13-14, 2021 Dr. Williams will deliver his corporate presentation at12:20pm ET onMay 13, 2021 .Dr. Williams will also participate in a panel discussion titled “Investing Post COVID – Back to the Fundamentals” at11:50am ET onMay 13, 2021 . The panel will discuss healthcare investing in the post COVID world.- Investors may request one-on-one meetings with
Dr. Williams . - Investors may register for the conference here: https://www.benzinga.com/events/small-cap/global/.
- Q2 Investor Summit:
May 17-18, 2021 Dr. Williams will deliver his corporate presentation at2:00pm ET onMay 17, 2021 .- Investors may request one-on-one meetings with
Dr. Williams . - Investors may register for the conference here: https://investorsummitgroup.com/.
- 2021
LD Micro Invitational Investor Conference :June 8-10, 2021 Dr. Williams will deliver his corporate presentation at12:00pm ET onJune 9, 2021 .- Investors may request one-on-one meetings with
Dr. Williams . - Investors may register for the conference here: https://ldmicrojune2021.mysequire.com/.
- MarketsandMarkets 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition: June 28-30, 2021
Dr. Williams will be speaking at the scientific conference at11:30am ET onJune 29, 2021 .- The topic is “Personalized, off-the-shelf cellular immunotherapy for cancer”.
- A copy of the presentation will be posted here: https://briacell.com/novel-technology/scientific-publications/.
- For additional information on the conference and the speaker, please visit:
https://events.marketsandmarkets.com/4th-annual-next-gen-immuno-oncology-virtual-congress-us-edition/speakers
Separately, BriaCell has recently appointed
About
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.
For additional information on BriaCell, please visit: https://briacell.com/.
Forward Looking Statements
This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” "will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Company’s
Neither
Contact Information
Company Contact:
President & CEO
1-888-485-6340
info@briacell.com
Media Relations:
Director of Public Relations
CORE IR
917-885-7378
julesa@coreir.com
Investor Relations Contact:
CORE IR
investors@briacell.com
Source:
2021 GlobeNewswire, Inc., source